Clinical trial
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A…
NCT00284193 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00284193 |
|---|---|
| Title | Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII |
| Official title | Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hemophilia A |
| Intervention type | Drug |
| Interventions | rFVIIa-FEIBA therapy for hemophilia A inhibitors, FEIBA- Activated Prothrombin Complexes |
| Enrollment | 5 |
| Start date | Jan 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Jan 31, 2006 |
| Last update posted | Jul 27, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: